Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Changes to the board committees

2 Dec 2020 15:30

RNS Number : 3281H
Stenprop Limited
02 December 2020
Β 

Β 

Β 

Β 

Β 

Β 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

Β 

CHANGES TO THE BOARD COMMITTEES

Β 

2 December 2020

Β 

Β 

Following the appointments of Louisa Bell and Richard Smith to Stenprop's board of directors (the "Board") on 4 November 2020, shareholders are advised that the following changes were made to the composition of the various Board committees on 2 December 2020:

Β 

Β· Louisa Bell was appointed to the audit and risk committee, the remuneration committee and the social and ethics committee;

Β· Richard Smith was appointed to the audit and risk committee and the remuneration committee;

Β· Richard Grant stood down from the audit and risk committee and from the social and ethics committee;

Β· Patsy Watson was appointed to the social and ethics committee; and

Β· Julian Carey, Managing Director, and James Wakelin, Head of debt and special projects, were appointed as executive members to the social and ethics committee whilst Sarah Bellilchi stood down from the committee.

Β 

Following these changes, the composition of the Board committees is as follows:

Β 

Board committee

Members

Audit and risk committee

Phil Holland (chair), Paul Miller, Louisa Bell and Richard Smith

Remuneration committee

Paul Miller (chair), Richard Grant, Phil Holland, Louisa Bell and Richard Smith

Nomination committee

Social and ethics committee

Richard Grant (chair), Paul Miller, Phil Holland and Patsy Watson

Phil Holland (chair), Patsy Watson, Louisa Bell, Julian Carey and James Wakelin

Β 

With the appointments of Richard and Louisa and the changes to the Board committees described above, Stenprop is now fully compliant with the provisions of the UK Corporate Governance Code and the King IV Report on Corporate Governance for South Africa in terms of the composition of the Board and its committees and the balance of independent and non-independent directors on the Board.

Β 

Β 

For further information:

Β 

Stenprop Limited +44(0)20 3918 6600

Paul Arenson (paul.arenson@stenprop.com)

Julian Carey (julian.carey@stenprop.com)

James Beaumont (james.beaumont@stenprop.com)

Β 

Β 

Β 

Numis Securities Limited (Financial Adviser) +44(0)20 7260 1000

Hugh Jonathan

Vicki Paine

Justin Bell

Β 

FTI Consulting +44(0)20 3727 1000

Richard Sunderland stenprop@fticonsulting.com

Richard Gotla

Indraneel Bose

Β 

Java Capital Trustees and Sponsors Proprietary Limited +27 (0)11 722 3050

(JSE Sponsor)

Β 

About Stenprop:

Β 

Stenprop is a UK REIT listed on the LSE and the JSE. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to stenprop.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAMZMGZKZRGGZM
Date   Source Headline
18th Oct 20077:01 amRNSFinal Results
20th Aug 20077:01 amRNSAIM Rule 26 and Adviser Name
30th Jul 20077:01 amRNSBank Loan Facility
18th Jul 20075:29 pmRNSHolding(s) in Company
28th Jun 20077:03 amRNSTrading Update
18th Jun 20077:01 amRNSMajor VoIP Customer Trial
4th Jun 20074:21 pmRNSNotice of EGM
31st May 20077:00 amRNSTotal Voting Rights
23rd May 200711:43 amRNSDirectorate Change
9th May 20075:04 pmRNSGrant of Options
4th May 20075:40 pmRNSNotifiable Interest
25th Apr 20075:52 pmRNSNotifiable Interest
11th Apr 20075:00 pmRNSHolding(s) in Company
4th Apr 20072:40 pmRNSConvertible Equity Facility
3rd Apr 20078:48 amRNSDirectorate Change
5th Mar 20077:04 amRNSDirectorate Change
5th Mar 20077:01 amRNSAcquisition
5th Feb 20077:02 amRNSTelstra Platinum Partner
2nd Feb 200712:00 pmRNSGrant of Options
30th Jan 20077:02 amRNSInterim Results
11th Dec 20064:15 pmRNSVoting Share capital
6th Dec 20067:01 amRNSDeputy Chairman Appointment
28th Nov 20062:34 pmRNSNotice of EGM
27th Nov 200612:02 pmRNSIssue of Equity
27th Nov 20067:02 amRNSOxfam 118 918 Partnership
30th Oct 20067:02 amRNSAnnual Report and AGM Notice
19th Oct 20067:00 amRNSIssue of Equity
16th Oct 20067:01 amRNSAcquisition
29th Sep 20067:06 amRNSIssue of Equity
12th Sep 20067:04 amRNSAcquisition of Callplan Ltd
29th Aug 20062:15 pmRNSIssue of Equity
28th Jul 20062:06 pmRNSAward of Share Options
27th Jul 200612:29 pmRNSBuy-out of Spiritel Tech
25th Jul 20067:01 amRNSDirector's Dealing
24th Jul 20067:01 amRNSDirector's dealings
21st Jul 200612:27 pmRNSIssue of Equity
19th Jul 200612:13 pmRNSDebt Restructuring
5th Jul 20067:01 amRNSIssue of Convertible Loan
21st Jun 20067:02 amRNSLaunches VoipVoucher
28th Apr 20061:11 pmRNSResult of EGM
6th Apr 20062:08 pmRNSNotice of EGM
6th Apr 20067:01 amRNSBoard Changes
31st Mar 20065:28 pmRNSNotification of Interest
27th Mar 20067:02 amRNSSigns 1st My Phone Agreement
24th Mar 20064:40 pmRNSNotification of Interest
20th Mar 20067:02 amRNSManaged Services Contract
6th Mar 20067:03 amRNSLoan Note Conversion
3rd Mar 20066:27 pmRNSLoan Note Conversion
22nd Feb 20061:39 pmRNSNotification of Interest
21st Feb 20065:50 pmRNSDirectors' Dealing-Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.